Profitable Specialty Pharmaceuticals Company Investment Opportunity in Hyderabad, India

We are working with five clients.

We are a research-based product development partner to pharmaceutical companies.

Promoter experience: Promoter is a pharmaceutical professional with 18+ years of work experience (Formulation scientist) turned to healthcare entrepreneur.

In 3 years, business will reach USD 2 million revenue per year.

We signed up new clients this year and have already achieved INR 1 Cr for this year.

More clients are in the pipeline.

We generate almost equal revenue from fee for service model and in-house asset sale model.

1. Fee for Service model - Standalone Analytical services and Product development services.

2. In-house assets development for tec pack/dossier selling or out-licensing.

Pleiades will develop, manufacture, and out license its generics and complex generic medicines. such as niche product segments like anti-cancer, anti-cancer adjuvants, anti-coagulants, anti-diabetic, rare.

Disease, and critical care medicines for global markets.

Tangible Assets:

Analytical equipment: Rs 3,20,00,000.

Formulations equipment: Rs 2,40,00,000.

Intangible assets: Rs 7,00,00,000.

4 anti-diabetic and 1 anticoagulant for global market filing.

5 molecules for domestic and RoW market filing.

We have research and development facility built in 8,000 square feet area in IDA Jeedimetla, Hyderabad, India in a rented premises.

Promoters raised INR 4 Cr by bootstrapping and INR 3.6 Cr by debt loan from bank. Total number of investors are two. Shareholding pattern is 51:49.